Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Lexington, Kentucky Clinical Trials

A listing of Lexington, Kentucky clinical trials actively recruiting patient volunteers.

RESULTS

Found (17) clinical trials

A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation

The intended patient population is applicable for Lungpacer DPT because there are no noninvasive alternative treatments for patients who are difficult to wean from MV (i.e., 96 hours (4 days) on MV) or who have required prolonged MV (>7 days). The intended patient population includes approximately one-third of all patients ...

Phase N/A

0.0 miles

Learn More »

Researchers at the University of Kentucky are inviting you to participate in a survey-based study to assess beliefs and behaviors about colorectal cancer screening.  

Phase N/A

1.43 miles

Learn More »

Evaluation of an Enhanced Delivery Model for Go NAPSACC

This research study will use a type 3 hybrid effectiveness-implementation design with a randomized controlled trial to evaluate the impact of Go NAPSACC when using basic vs enhanced implementation models (i.e., Basic Go NAPSACC vs. Enhanced Go NAPSACC). To evaluate impact, measures collected at baseline and post-intervention will be used ...

Phase N/A

1.43 miles

Learn More »

What is the Zoster Eye Disease Study (ZEDS)? ZEDS is a clinical trial investigating whether long-term treatment with a pill, Valacyclovir, will help reduce eye disease and/or chronic pain in patients with shingles a­ ecting the eye. Talk to your eye doctor to learn more. ZEDS is funded by the ...

Phase N/A

1.43 miles

Learn More »

Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

PRIMARY OBJECTIVES: I. To evaluate the overall response rate (ORR) (confirmed and unconfirmed, complete and partial) associated with rucaparib in patients with genomic LOH high and/or deleterious BRCA1/2 mutations within: Cohort 1: Patients with squamous cell histology or mixed histology with a squamous component; Cohort 2: Patients with non-squamous histology ...

Phase

1.61 miles

Learn More »

A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis

The purpose of this study is to evaluate the efficacy, safety, pharmacodynamic (PD) and pharmacokinetic (PK) effect of VX-561.

Phase

1.61 miles

Learn More »

Neural Mechanisms of Cannabinoid-impaired Decision-Making in Emerging Adults

This mentored career development award (K01) will enable Dr. Michael J. Wesley to achieve his long-term goal of becoming an independent investigator with a clinical research program examining cannabis use disorder (CUD) in emerging adults, which is a current NIDA funding priority. Dr. Wesley is a new Assistant Professor at ...

Phase N/A

2.07 miles

Learn More »

Behavioral Effects of Drugs (Inpatient): 38

The specific aim of this project is to demonstrate that the decisional analysis/craving regulation aspects of CBT reduce cocaine self-administration in subjects with cocaine use disorder through diminished craving responses. Thirty non-treatment seeking human subjects meeting diagnostic criteria for cocaine use disorder will complete an outpatient, crossover, placebo-controlled study consisting ...

Phase N/A

2.07 miles

Learn More »

The Impact of Dosing Parameters on Motor Skill Acquisition and Retention in Bilateral Cerebral Palsy (BCP)

Cerebral Palsy (CP) is the leading cause of childhood motor impairment with 1 in 323 American children affected. The resulting impaired motor function in individuals with CP limits their ability to independently perform many functional activities, and participate in academic, social, and leisure activities. Children with CP are referred to ...

Phase N/A

2.46 miles

Learn More »

The purpose of the study is to see how safe it is and how well you tolerate changing the MS medicine you are taking currently for your MS to siponimod (an investigational drug for MS). The results of this study will help doctors decide if and when to switch patients ...

Phase

2.59 miles

Learn More »